Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: Results from a multicenter trial
Clinical TherapeuticsPublished 1 June 2003
Horacio Pérez López, Jim Z. Li, Dan A. Balan, Richard J. Willke, B Rittenhouse, Essy Mozaffari
Citations19
SJR quartileQ1
SJR score0.98
SNIP1.02
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Linezolid was associated with shorter LOS and duration of IV antibiotic treatment than teicoplanin for serious gram-positive infections in the population studied and has the potential to reduce the total cost of treatment.
Abstract
Linezolid was associated with shorter LOS and duration of IV antibiotic treatment than teicoplanin for serious gram-positive infections in the population studied. Linezolid therapy has the potential to reduce the total cost of treatment.
Keywords
Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology
EconometricaA Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
26,139 Citations1980Halbert White
CHEST JournalDefinitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
13,045 Citations1992Roger C. Bone, R.A. Balk +6 more
Broad definitions of sepsis and the systemic inflammatory response syndrome were proposed, along with detailed physiologic parameters by which a patient may be categorized, and the use of severity scoring methods when dealing with septic patients was recommended as an adjunctive tool to assess mortality.
Applied survival analysis: regression modeling of time-to-event data
3,039 Citations2008David W. Hosmer, Stanley Lemeshow +1 more
Journal of Antimicrobial ChemotherapyMethicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
1,980 Citations1997Keiichi Hiramatsu
Therapy was resumed with the com -bination of arbekacin and ampicillin/sulbactam which has been shown to have synergic activity against MRSA.
Clinical Infectious DiseasesNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
1,387 Citations1999Michael B. Edmond, Sarah E. Wallace +4 more
Concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections, and coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common.
Clinical Infectious DiseasesLinezolid versus Vancomycin for the Treatment of Methicillin‐Resistant <i>Staphylococcus aureus</i> Infections
511 Citations2002Dennis L. Stevens, Daniel Herr +5 more
Hospitalized adults with known or suspected methicillin-resistant Staphylococcus aureus infections were treated with linezolid or vancomycin, and both regimens were well tolerated, with similar rates of adverse events.
Emerging infectious diseasesNosocomial Infection Update
442 Citations1998Robert A. Weinstein
To prevent and control these emerging nosocomial infections, the need to increase national surveillance, "risk adjust" infection rates so that interhospital comparisons are valid, develop more noninvasive infection-resistant devices, and work with health-care workers on better implementation of existing control measures such as hand washing.
Clinical Infectious DiseasesLinezolid (PNU-100766) versus Vancomycin in the Treatment of Hospitalized Patients with Nosocomial Pneumonia: A Randomized, Double-Blind, Multicenter Study
441 Citations2001Eric Rubinstein, Sue Cammarata +3 more
Linezolid is a well-tolerated, effective treatment for adults with gram-positive nosocomial pneumonia and Eradication rates of methicillin-resistant Staphylococcus aureus and safety evaluations were similar between treatment groups.
Clinics in Chest MedicineANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITS
327 Citations1999Scott K. Fridkin, Robert P. Gaynes
The unique nature of the intensive care unit (ICU) environment makes this part of the hospital a focus for the emergence and spread of many antimicrobial-resistant pathogens, and rates are almost universally higher among ICU patients compared with non-ICU patients.
Infection Control and Hospital EpidemiologyNosocomial Methicillin-Resistant and Methicillin-Susceptible<i>Staphylococcus Aureus</i>Primary Bacteremia: At What Costs?
316 Citations1999Murray A. Abramson, Daniel J. Sexton
Primary nosocomial BSIs due to MRSA result in an approximate threefold increase in direct cost, compared with those due to MSSA, which significantly prolongs the hospital stay.
Clinical Microbiology ReviewsCurrent perspectives on glycopeptide resistance
297 Citations1995Neil Woodford, Alan P. Johnson +2 more
Glycopeptide-resistant enterococci have emerged as a particular problem in hospitals, where in addition to sporadic cases, clusters of infections with evidence of interpatient spread have occurred.
Clinical Microbiology ReviewsResistance to vancomycin and teicoplanin: an emerging clinical problem
245 Citations1990Alan P. Johnson, A.H.C. Uttley +2 more
The selective advantage accorded to glycopeptide-resistant bacteria and the observation that high-level resistance in enterococci is transferable suggest that such resistance may be expected to increase in incidence.
Antimicrobial Agents and ChemotherapyRandomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections
241 Citations2000Dennis L. Stevens, Leon G. Smith +5 more
The use of linezolid for the treatment of adults with complicated skin and soft tissue infections is supported, and both agents were well tolerated; most adverse events were of mild-to-moderate intensity.
Journal of Antimicrobial ChemotherapyThe comparative efficacy and safety of teicoplanin and vancomycin
232 Citations1996Marsha Wood
Treatment with teicoplanin might offer advantages over treatment with vancomycin-provided that similar clinical efficacy can be shown, and its superior tolerability together with advantages such as once-daily bolus administration, intramuscular use and lack of requirement for routine serum monitoring, give it considerable potential for use in clinical practice.
The American Journal of MedicineClinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
163 Citations1991Joseph A. Paladino, Howard E. Sperry +5 more
When used after 3 days of intravenous antibiotics, oral ciprofloxacin was as safe and effective as full courses of intravenOUS antibiotics and provided substantial cost savings.
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyComparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin‐Resistant <i>Staphylococcus</i> Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial
129 Citations2001Zhiming Li, Richard J. Willke +7 more
To compare hospital length of stay, weekly discharges, and days of antibiotic treatment with linezolid (intravenous with oral follow‐up) and vancomycin (intranasal only), it is necessary to establish a baseline level of trust in the use of these antibiotics.
New England Journal of MedicineNew Resistance in<i>Staphylococcus aureus</i>
129 Citations1999F. A. Waldvogel
This was the semisurprised reaction of the microbiologic and medical community in 1997 to a well-documented report from Japan that vancomycin resistance was emerging as the latest setback in the war against bacteria.
Annals of Internal MedicineVancomycin-Resistant <i>Staphylococcus aureus</i>: Perspectives on Measures Needed for Control
127 Citations1996Michael B. Edmond, Richard P. Wenzel +1 more
It seems likely that vancomycin-resistant S. aureus will emerge as a nosocomial pathogen with disastrous consequences if widespread Nosocomial transmission occurs, and hospitals should adopt a proactive approach to isolation guidelines.
Health EconomicsResource costing for multinational neurologic clinical trials: methods and results
98 Citations1998Kevin A. Schulman, Jennifer E. Burke +12 more
The study describes a framework for the collection and analysis of international resource cost data that can contribute to a consistent and accurate intercountry estimation of cost and suggest guidelines to facilitate more effective multinational costing exercises.
The Pediatric Infectious Disease JournalLinezolid for the treatment of community- acquired pneumonia in hospitalized children
86 Citations2001Sheldon L. Kaplan, L. E. R. Patterson +7 more
Linezolid was well-tolerated and could be considered an alternative to vancomycin for treating serious infections caused by antibiotic-resistant Gram-positive cocci in children pending results of additional studies.
CHEST JournalOverview of Resistance in the 1990s
76 Citations1999Thomas M. File
Owing to the high rate of antibiotic use and other risk factors, a person is more likely to acquire an antibiotic-resistant infection in the ICU than anywhere else, either inside or outside the hospital.
Annals of PharmacotherapyPharmacoeconomic Benefit of Antibiotic Step-Down Therapy: Converting Patents from Intravenous Ceftriaxone to Oral Cefpodoxime Proxettl
73 Citations1995Joseph R Hendrickson, Donald S. North
Pharmacist intervention and cefpodoxime step-down therapy were associated with decreased overall antibiotic costs in the authors' intravenous-to-oral program.
Clinical Infectious DiseasesVancomycin‐Resistant<i>Staphylococcus aureus</i>: Infection Control Considerations
70 Citations1998Richard P. Wenzel, Michael B. Edmond
The antibiotic era is continually threatened by inappropriate decisions regarding use, inappropriate choices, and unnecessary durations of treatment, so efforts to identify and isolate resistant organisms introduced from outside institutions are essential.
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyA Pharmacist‐Initiated Program of Intravenous to Oral Antibiotic Conversion
68 Citations1997Kevin G. Przybylski, Michael J. Rybak +5 more
The intervention program appeared to provide a cost‐effective conversion from parenteral to oral antimicrobial administration without compromising patient care and it is anticipated that expansion of the program to include additional antibiotics will result in even greater cost savings for the institution.
Infectious Disease Clinics of North AmericaTHE SLEEPING GIANT
48 Citations1994José María Casellas, Manuel Guzmán Blanco +1 more
Wiser and more restrictive usage of the currently available antibiotics is needed and this may be obtained through education and with the amplification of national and supranational networks of surveillance, which could anticipate trends in resistance.
International Journal of Infectious DiseasesThree year surveillance study of nosocomial bacterial resistance in Argentina
44 Citations2000Carlos Bantar, Àngela Famiglietti +1 more
The alarming rates of resistance found in this study provide compelling evidence of the need for more rational use of antimicrobial agents in Argentina.
International Journal of Antimicrobial AgentsClinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic
35 Citations2000Giampaolo Corti, Roberta Cinelli +1 more
Linezolid, a member of the new class of synthetic antimicrobials named oxazolidinones, has several favourable characteristics including high activity against multiresistant Gram-positive cocci, and can be considered a valid option for treating both community- and hospital-acquired infections due to multi-resistant Gram- positive cocci.
PharmacoEconomicsCost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
29 Citations1999Daniel J. Walters, Joseph S. Solomkin +1 more
In patients able to receive oral therapy, sequential IV to oral treatment with ciprofloxacin plus metronidazole was cost effective compared with full IV courses of cipronidzole or imipenem-cilastatin.
Current Opinion in Infectious DiseasesSequential antibiotic therapy
29 Citations2000Gavin Barlow, Dilip Nathwani
Key questions, such as what is the optimal time of switch for specific infections, and can conditions such as osteomyelitis and endocarditis be efficaciously treated with oral therapy, need to be answered and clinicians will be able to practise evidence-based infection management incorporating sequential antimicrobial therapy.
CHEST JournalSequential Switch Therapy for Lower Respiratory Tract Infections
27 Citations1998Dilip Nathwani
The current published literature regarding the practice of switch therapy for LRTIs is reviewed, examining the evidence for efficacy, safety, appropriate timing of the switch, the economic benefits, and the suitability of various antibiotics.
Journal of InfectionSequential antibiotic therapy: the right patient, the right time and the right outcome
26 Citations1998Peter Davey, Dilip Nathwani
Hospitals must develop policies for sequential therapy which define standards against which clinical care can be audited, and research on sequential therapy is undoubtedly required, with particular emphasis on the reliability of absorption of oral drugs by hospitalized patients.
Journal of Hospital InfectionEconomic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model
26 Citations2001Angela G Vinken, Z. Li +4 more
Investigating the hypothesis that linezolid is an appropriate choice when considering empirical treatment of cellulitis in complicated or compromised patients in the nosocomial setting found it to result in higher overall success rates and be less costly than vancomycin across the entire spectrum of the patients' risk of being infected by a resistant pathogen.
PubMedEffects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis.
22 Citations2002Richard J. Willke, Henry A. Glick +2 more
Linezolid treatment resulted in statistically significantly shorter hospital LOS as compared with vancomycin treatment, which may allow some patients to be discharged earlier than would treatment with intravenous vancomYcin.
Infection Control and Hospital EpidemiologyAntibiotic Cycling and Marketing Into the 21st Century: A Perspective From the Pharmaceutical Industry
20 Citations2000Bruce Lavin
To be successful, the pharmaceutical industry must anticipate the changing needs of the medical community, as well as the dynamic process of antimicrobial resistance, and adaptable to the potential environmental pressures that induce bacterial resistance in order to ensure the longevity of the agents.
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyManaging Antiinfective Therapy of Community‐Acquired Pneumonia in the Hospital Setting: Focus on Switch Therapy
16 Citations2001Julio A. Ramírez
It is shown that switch therapy can be implemented safely when four criteria are met: cough and respiratory distress improve, fever abates for at least 8 hours, white blood cell count is returning to normal, and patient can take drugs orally.
International Journal of Antimicrobial AgentsDiscussion
13 Citations1999D. Nathwani, M. Malek
The costs associated with infection by a resistant organism, the pharmacoeconomic arguments when considering a new drug and the key decisions when evaluating a newDrug such as linezolid, for inclusion in a formulary or policy with particular reference to the treatment of serious Gram-positive infections are outlined.
Canadian Journal of Infectious Diseases and Medical MicrobiologyIntravenous to Oral Antimicrobial Therapy Stepdown Therapy: Improving the Quality of Care and Reducing Costs
5 Citations1995John Conly, Donald E. Low
PubMedEstablishing value through pharmacoeconomics: the emerging third objective in clinical trials.
5 Citations1994Boyer Jg, Pathak Ds
The protocol, the informed consent form, the data collection instruments, the study initiation, and the final study report are discussed.